article thumbnail

How direct-to-patient clinical trial models can accelerate speed-to-market

The Pharma Data

Analyzing the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency and accelerate speed to market. Download Your Copy. The benefits of developing a patient-centric clinical supply chain.

article thumbnail

State of Clinical Inventory and Sample Management for Clinical Trials

Fierce BioTech

State of Clinical Inventory and Sample Management for Clinical Trials This report summarizes the survey findings from biopharma professionals on the impacts of inefficient, manual processes for managing clinical supply and samples on budgets, timelines, data integrity, and patients — and the need for change.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nordic Nanovector ASA: Results for the Third Quarter 2020

The Pharma Data

These restrictions and uncertainty around the duration, severity and geographic scope of the COVID-19 outbreak are projected to slow down the enrolment of patients due to re-prioritisation of hospital activities towards COVID-19 patients and away from clinical studies such as PARADIGME. This information was brought to you by Cision [link].

Trials 40
article thumbnail

Transform Your CDMO Experience By Choosing The Right Partner

Fierce BioTech

Download now. Download now. Avid Bioservices CDMO Clinical Supply Supply Chain Resource Type Whitepaper Avid Bioservices Listing Logo Thu, 02/06/2025 - 11:32 Manufacturing Drug Delivery Manufacturing Pharma Landing Page Url [link] Byline Sponsored by: Avid Bioservices